The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center-Reference-Cited by-同舟云学术

The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center

Published:2019-11-12 Issue:3 Volume:39 Page:813-821
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Yang Luwei,Wang Qian,Hou Yong,Zhao Jiuliang,Li Mengtao,Xu Dong,Zeng Xiaofeng

Funder

the National Key Research and Development Program of China Grant

Center for Rare Diseases Research, Chinese Academy of Medical Sciences, Beijing, China

Grant from CAMS Innovation Fund for Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-019-04784-y.pdf

Reference34 articles.

1. Xu D, Li MT, Hou Y et al (2011) Preliminary analysis of Chinese patients with systemic sclerosis. Chin J Rheumatol 7:455–459

2. Giacomelli R, Liakouli V, Berardicurti O et al (2017) Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol Int 37(6):853–863

3. Dimitroulas T, Giannakoulas G, Karvounis H, Settas L, Kitas GD (2012) Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets. Curr Pharm Des 18(11):1457–1464

4. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66(7):940–944

5. Tashkin DP, Roth MD, Clements PJ et al (2016) Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 4(9):708–719

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global research status and trends of interactions between Traditional Chinese medicine and pulmonary fibrosis: A new dawn in treatment;Heliyon;2024-07

2. Demethylzeylasteral protects against renal interstitial fibrosis by attenuating mitochondrial complex I-mediated oxidative stress;Journal of Ethnopharmacology;2024-06

3. Traditional Chinese Medicine Integrated Responsive Microneedles for Systemic Sclerosis Treatment;Research;2023-01

4. Traditional Herbal Medicines, Bioactive Compounds, and Plant Products as Therapeutic Approach Against Interstitial Lung Disease;Genetic Manipulation of Secondary Metabolites in Medicinal Plant;2023

5. Application of herbal traditional Chinese medicine in the treatment of lupus nephritis;Frontiers in Pharmacology;2022-11-24